Btai deadline: rosen, national investor counsel, encourages bioxcel therapeutics, inc. investors with losses to secure counsel before important september 5 deadline in securities class action - btai

New york , sept. 2, 2023 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of bioxcel therapeutics, inc. (nasdaq: btai) between december 15, 2021 and june 28, 2023, both dates inclusive (the "class period"), of the important september 5, 2023 lead plaintiff deadline.
BTAI Ratings Summary
BTAI Quant Ranking